International Journal of Radiation Oncology*Biology*Physics
Volume 114, Issue 3, Supplement, 1 November 2022, Pages e244-e245
2545Challenges and Solutions during the COVID Pandemic for Patient Retention and Physician Engagement in the Phase 3 ATLAS Study of Apalutamide Added to Androgen Deprivation Therapy (ADT) in High-Risk Localized or Locally Advanced Prostate Cancer (HRLPC)
References (0)
Cited by (0)
Copyright © 2022 Published by Elsevier Inc.